Domain Adoption: Senior Analyst, Metabolic Medicine and Ketogenic Therapy

Abstract

This presentation addresses target blood ketone levels (specifically beta-hydroxybutyrate, $\beta$OHB, measured in mM/L) for individuals undergoing ketogenic therapy for various metabolic and brain-based disorders, including Type 2 Diabetes (T2D), seizure control, and psychiatric conditions. The material emphasizes that individualized clinical response, not a standardized number, should dictate therapeutic goals. Expert consensus and published literature suggest specific target ranges: for T2D remission, 0.5–1.5 mM/L is generally adequate; for seizure control, 2.5–4.0 mM/L is standard; and for serious mental illness, 1.5–3.0 mM/L is often targeted, though high inter-individual variability is observed. The presentation also critically reviews the traditional definition of ketoacidosis (DKA) in the context of therapeutic nutritional ketosis, cautioning that levels up to 5.0 mM/L may be routine for healthy individuals on a ketogenic diet, but any elevated $\beta$OHB accompanied by signs of metabolic distress (nausea, confusion, acidosis) requires immediate medical intervention.

Ketone Level Targets in Ketogenic Therapy

• 0:02 Introduction to Ketogenic Therapy Monitoring: Individuals using a ketogenic diet for psychiatric disorders, Type 2 Diabetes (T2D), Polycystic Ovary Syndrome (PCOS), or dementia can measure their therapeutic response via circulating ketone levels.
• 1:19 Guiding Principle: The objective is to provide a framework for understanding the role of ketone levels, stressing that targets must be determined in collaboration with a healthcare team based on individual goals.
• 1:33 Goal Level Summary (Blood $\beta$OHB in mM/L):
  • Weight Loss: Ketone levels may not be highly critical; adherence to the prescribed diet is paramount.
  • Diabetes Remission: Optimal range is likely between 0.5 and 1.5 mM/L.
  • Seizures: Target range is typically 2.5 and 4.0 mM/L.
  • Serious Mental Illness: Target range is estimated between 1.5 and 3.0 mM/L, with potential for slightly higher required levels.
• 2:48 Measurement Methods: Ketone levels can be measured using finger-stick blood testing for $\beta$OHB (the most common and accurate method cited) or breath meters for acetone. Urine strips are discouraged for quantitative level assessment.
• 3:15 Nutritional Ketosis Baseline: Nutritional ketosis is generally defined as beginning at 0.5 mM/L.
• 3:47 T2D Clinical Data: For T2D, levels over 0.5 mM/L are recommended. Studies by Virta Health showed T2D remission in up to 60% of participants, where $\beta$OHB levels rarely exceeded 1.5 mM/L, with an average around 0.5 mM/L.
• 4:10 Brain-Based Disorder Targets: For seizure control, evidence-based guidelines commonly recommend 2.5 to 4.0 mM/L in pediatric populations.
• 4:27 Psychiatric Condition Targets and Variation: Less evidence exists than for seizure control, but 1.5 to 3.0 mM/L is a reasonable target. Significant individual variability is noted; some experts suggest levels above 2.0 mM/L correlate with better outcomes, while clinical benefit has been observed in some patients maintaining $\beta$OHB above 0.5 mM/L only 60% of the time.
• 5:56 Safety Threshold Critique: The traditional American Diabetes Association guideline defining ketoacidosis (DKA) as a $\beta$OHB level above 3.8 mM/L is contextually flawed, as this definition is based on non-ketogenic, high-carb consuming populations.
• 6:37 Normal Therapeutic Ranges: Individuals adhering to a ketogenic diet may routinely register ketone levels of 5.0 mM/L or higher while remaining clinically well.
• 7:07 DKA Warning: Any elevated ketone level, regardless of the patient's diet, associated with symptoms such as nausea, vomiting, dehydration, mental confusion, or objective signs of acidosis, must be treated immediately as a potential medical emergency.